Ph.D., Assistant Professor, University of California Santa Cruz
Daniel H. Kim, PhD is an Assistant Professor of Biomolecular Engineering at the University of California Santa Cruz and faculty member of the UCSC Genomics Institute, Center for Molecular Biology of RNA, Institute for the Biology of Stem Cells, and the California Institute for Quantitative Biosciences. His laboratory investigates the functions of noncoding RNA “dark matter” in stem cells and cancer using genomic and genome engineering technologies, including single cell RNA sequencing and CRISPR-based approaches. Leveraging the unique properties of noncoding RNA, his research program aims to discover novel biomarkers for cancer detection and immunotherapy. His noncoding RNA research has been recognized by awards from the Damon Runyon Cancer Research Foundation and the National Academy of Sciences.
Presentation Title and Company Description
Immunotherapy Showcase: ctDNA in the Routine Management of Cancer Patients: Opportunities and Challenges
The Daniel Kim Lab at UC Santa Cruz investigates RNA “dark matter” and has recently discovered highly-specific RNA signatures of the earliest stages of cellular transformation. Early detection of cancer would potentially provide an opportune window for immunotherapy-based interventions.